Related Experiment Videos
Acute interstitial nephritis associated with ticlopidine
H Rosen1, A S el-Hennawy, S Greenberg
1Department of Medicine, Coney Island Hospital, Brooklyn, NY 11235, USA.
Summary
Ticlopidine, a platelet aggregation inhibitor, can cause acute interstitial nephritis. This case report details a patient who developed kidney failure after starting ticlopidine treatment.
Area of Science:
- Nephrology
- Pharmacology
- Immunology
Background:
- Ticlopidine is a platelet aggregation inhibitor used to reduce the risk of thrombotic stroke.
- Adverse drug reactions can impact various organ systems, including the kidneys.
Observation:
- A 75-year-old woman experienced acute renal failure 10 days after beginning ticlopidine therapy.
- Renal biopsy findings included interstitial infiltrates with lymphocytes and eosinophils.
Findings:
- This case presents the first reported instance of ticlopidine-induced acute interstitial nephritis.
- The patient's renal failure was attributed to an immune-mediated reaction to ticlopidine.
Implications:
- Clinicians should be aware of the potential for ticlopidine to cause acute interstitial nephritis.
- Early recognition and discontinuation of ticlopidine may be crucial for managing this adverse effect.
- Further research into the mechanisms of drug-induced kidney injury is warranted.